Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alexar formed by NeXeption; raises $21.5mm through its Series A round

Executive Summary

Biopharma management company NeXeption LLC formed Alexar Therapeutics Inc. (dermatology compounds) in conjunction with a $21.5mm Series A venture round. New Science Ventures and Third Point Ventures led (and each contribute one board member) and were joined by Palo Alto Investors.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register